Company profile

Ticker
VAR
Exchange
CEO
Dow R. Wilson
Employees
Incorporated in
Location
Fiscal year end
Former names
Varian Associates Inc
SEC CIK
IRS number
942359345

VAR stock data

(
)

Calendar

7 Aug 19
25 Aug 19
27 Sep 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 825.8M 779.4M 741M 801.6M
Net income 29.4M 88.6M 103.2M 116.4M
Diluted EPS 0.32 0.96 1.12 1.26
Net profit margin 3.56% 11.37% 13.93% 14.52%
Operating income 53.9M 109.8M 111.7M 137.3M
Net change in cash -25.6M -69.7M 111.2M -31.2M
Cash on hand 520.7M 546.3M 616M 504.8M
Cost of revenue 474.4M 461.2M 424.9M 462.9M

Financial data from company earnings reports

Financial report summary

?
Risks
  • The decision by British voters to exit the European Union may negatively impact our operations.
  • Implementing or acquiring new lines of business or offering new products and services may subject us to additional risks.
  • The results of studies and clinical trials are highly uncertain.
  • Changes to radiation oncology, reimbursements, and insurance deductibles and administration may affect demand for our products.
Management Discussion
  • Our fiscal year is the 52- or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 is the 52-week period ending September 27, 2019, and fiscal year 2018 was the 52-week period that ended September 28, 2018. The fiscal quarters ended June 28, 2019 and June 29, 2018 were both 13-week periods.
  • Total product revenues increased in the three and nine months ended June 28, 2019, compared to the year-ago periods, primarily due to an increase in revenues from Oncology Systems. Total service revenues increased in the three and nine months ended June 28, 2019, compared to the year-ago periods, primarily due to an increase in revenues from Oncology Systems and, to a lesser extent, an increase in revenues from Proton Solutions. Revenues from the CTSI, Endocare and Alicon acquisitions increased revenues by $4.8 million in the three months ended June 28, 2019.
  • The Americas revenues increased in the three and nine months ended June 28, 2019, compared to the year-ago periods, due to an increase in revenues from Oncology Systems, partially offset by a decrease in revenues from Proton Solutions.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: ablation, aimed, Alicon, American, AmPath, APM, artificial, Austin, bead, begun, bland, Boston, brand, broad, BTG, cardiovascular, category, CHIP, CMS, cohort, coverage, cryoablation, CTSI, customary, disease, embolic, encouraged, Endocare, episodic, exceeded, fall, freestanding, Hangzhou, heart, holdback, hospital, hypervascular, imposition, increasingly, incubate, indirectly, inhibit, innovate, innovative, Institute, intelligence, interventional, invasive, joint, laboratory, Lanka, learning, liver, MACRA, Medicaid, microsphere, microwave, pathology, payor, pillar, pilot, PLC, Reauthorization, remote, residual, Scientific, space, specialty, Sri, stage, supplier, surgery, understaffed, undiscounted, uniform, venture, waiver, wider
Removed: cancelled, expired